Tobira Therapeutics (TBRA) Reports Q3 Loss of $1.22/Share

Tobira Therapeutics (NASDAQ: TBRA) reported Q3 EPS of ($1.22), versus ($7.29) reported last year.

For earnings history and earnings-related data on Tobira Therapeutics (TBRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15